Insider Selling: Cardlytics, Inc. (NASDAQ:CDLX) CFO Sells $59,235.45 in Stock

Cardlytics, Inc. (NASDAQ:CDLX) CFO Alexis Desieno sold 7,451 shares of the stock in a transaction that occurred on Tuesday, July 2nd. The stock was sold at an average price of $7.95, for a total transaction of $59,235.45. Following the completion of the transaction, the chief financial officer now owns 6,898 shares in the company, valued at $54,839.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Cardlytics Stock Performance

CDLX opened at $8.31 on Friday. The stock has a market capitalization of $405.39 million, a price-to-earnings ratio of -1.88 and a beta of 1.65. Cardlytics, Inc. has a fifty-two week low of $5.69 and a fifty-two week high of $20.52. The company has a debt-to-equity ratio of 1.30, a quick ratio of 2.13 and a current ratio of 2.13. The company has a fifty day moving average of $9.67 and a 200 day moving average of $9.54.

Cardlytics (NASDAQ:CDLX) last issued its earnings results on Wednesday, May 8th. The company reported ($0.35) earnings per share (EPS) for the quarter. Cardlytics had a negative return on equity of 25.36% and a negative net margin of 55.23%. The firm had revenue of $67.61 million during the quarter. As a group, sell-side analysts forecast that Cardlytics, Inc. will post -1.8 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently commented on CDLX shares. Needham & Company LLC restated a “buy” rating and issued a $12.00 price objective on shares of Cardlytics in a research note on Tuesday, June 11th. Northland Capmk upgraded Cardlytics to a “strong-buy” rating in a research report on Tuesday, June 18th. Lake Street Capital lifted their price objective on Cardlytics from $13.00 to $18.00 and gave the company a “buy” rating in a research report on Friday, March 15th. Craig Hallum reduced their target price on shares of Cardlytics from $18.00 to $12.00 and set a “buy” rating for the company in a report on Thursday, May 9th. Finally, Northland Securities started coverage on shares of Cardlytics in a research note on Tuesday, June 18th. They issued an “outperform” rating and a $14.00 price objective for the company. Two investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, Cardlytics has an average rating of “Moderate Buy” and a consensus target price of $12.67.

Institutional Trading of Cardlytics

Several hedge funds have recently modified their holdings of CDLX. Charles Schwab Investment Management Inc. increased its position in Cardlytics by 12.8% in the third quarter. Charles Schwab Investment Management Inc. now owns 283,086 shares of the company’s stock worth $4,671,000 after purchasing an additional 32,228 shares during the last quarter. Deutsche Bank AG grew its stake in shares of Cardlytics by 5.0% in the 3rd quarter. Deutsche Bank AG now owns 43,992 shares of the company’s stock worth $726,000 after buying an additional 2,093 shares in the last quarter. Invesco Ltd. increased its holdings in shares of Cardlytics by 538.1% in the 3rd quarter. Invesco Ltd. now owns 803,241 shares of the company’s stock worth $13,253,000 after buying an additional 677,354 shares during the last quarter. LPL Financial LLC raised its position in shares of Cardlytics by 27.5% during the 3rd quarter. LPL Financial LLC now owns 424,150 shares of the company’s stock valued at $6,998,000 after buying an additional 91,400 shares in the last quarter. Finally, Vanguard Group Inc. lifted its holdings in shares of Cardlytics by 13.0% in the 3rd quarter. Vanguard Group Inc. now owns 2,011,705 shares of the company’s stock valued at $33,193,000 after acquiring an additional 231,303 shares during the last quarter. 68.10% of the stock is owned by hedge funds and other institutional investors.

About Cardlytics

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.